Skip to main navigation Skip to search Skip to main content

The Addition of Gemcitabine to 131I-MIBG Therapy in Pediatric Patients with Relapsed or Progressive Neuroblastoma: An International Multi-Centre Phase II Trial (MIBG-GEM)

  • N. Van Eijkelenburg
  • , L. Tytgat
  • , M. van Noesel
  • , T. Simon
  • , B. Hero
  • , C. K. Li
  • , B. De Keizer
  • , A. C. J. Ammerlaan
  • , M. Lopez-Yurda
  • , C. M. Zwaan

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)S343-S344
JournalPediatric Blood & Cancer
Volume66
Publication statusPublished - Dec 2019

Cite this